Kimberly, W. T., O’Sullivan, J. F., Nath, A. K., Keyes, M., Shi, X., Larson, M. G., . . . Gerszten, R. E. (2017). Metabolite profiling identifies anandamide as a biomarker of nonalcoholic steatohepatitis. JCI Insight.
Chicago ZitierstilKimberly, W. Taylor, et al. "Metabolite Profiling Identifies Anandamide As a Biomarker of Nonalcoholic Steatohepatitis." JCI Insight 2017.
MLA ZitierstilKimberly, W. Taylor, et al. "Metabolite Profiling Identifies Anandamide As a Biomarker of Nonalcoholic Steatohepatitis." JCI Insight 2017.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.